文献速递神经肿瘤

1型神经纤维瘤病未选择患者队列中视路胶质瘤的自然史

Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
PubMed 文献 · J Neurooncol · 2017-06-02

该研究回顾性评估了414例6岁前转诊至神经纤维瘤病门诊的1型神经纤维瘤病(NF1)连续患者的视路胶质瘤(OPG)自然史,平均随访11.9年。52例(15.4%在15岁时累积发病率)诊断为OPG,性别间差异有统计学意义;筛查MRI诊断的OPG比例为12.5%,症状驱动MRI为36.4%(p=0.001)。多数患者保守治疗,8例因视力恶化接受治疗,筛查MRI诊断者视力结局均正常。

要点

  • 15岁时OPG累积发病率为15.4%(Kaplan-Meier估计),性别间差异有统计学意义。
  • 筛查MRI组OPG诊断率12.5% vs 症状驱动MRI组36.4%(p=0.001)。
  • 多数患者保守治疗,8例因视力恶化接受治疗;筛查MRI诊断者视力结局均正常。

核心结论

  • OPG位置与需要治疗不相关;女性患者更常受累但未更常接受治疗。
  • 筛查MRI诊断OPG不影响肿瘤的自然史。

研究设计与样本

  • 回顾性评估414例6岁前转诊至神经纤维瘤病门诊的NF1连续患者,平均随访11.9年。

主要发现

  • 52/414例患者诊断为OPG,15岁时累积发病率为15.4%(Kaplan-Meier估计),性别间差异有统计学意义。
  • 44.7%的患者接受了脑和眼眶MRI:其中34.6%为筛查目的,65.4%因存在神经、眼部或其他症状。
  • 筛查MRI组OPG诊断率为12.5%,症状驱动MRI组为36.4%(p=0.001)。
  • 多数患者临床管理为保守治疗,8例主要因视力恶化接受治疗;接受治疗的患者OPG诊断更早,但差异无统计学意义。
  • 所有接受筛查MRI的患者视力结局均正常。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Optic pathway glioma (OPG) represents the most common central nervous system tumor in children with Neurofibromatosis type-1 (NF1). Although overall survival is usually good, no clear prognostic factors have been identified so far. We assessed the natural history of OPG in a cohort of unselected patients affected by NF1. We retrospectively evaluated 414 consecutive patients affected by NF1 and referred to our NF1 clinic before age 6. Average follow-up was 11.9 years: 52 out of 414 patients had OPG with a total cumulative incidence of 15.4% at age 15 (Kaplan-Meier estimate) and a statistically significant difference according to sex. Brain and orbit MRI was performed in 44.7% of patients: 34.6% for screening purposes and 65.4% because of the presence of neurological, ocular or other symptoms. OPG was diagnosed in 12.5% of cases in the first group, whereas in 36.4% in the latter group (p = 0.001). Clinical management was conservative in most patients, while 8 of them underwent therapy mainly because of visual deterioration. OPG was diagnosed earlier in treated patients, but the difference was not statistically significant. Conversely, all patients who underwent screening MRI had normal visual outcome. In conclusion, OPG location does not correlate with need for treatment; female patients were more frequently affected by OPG but not more frequently treated. OPG diagnosis by screening MRI does not affect the natural history of the tumor.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Trevisson E, Cassina M, Opocher E, et al. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1. J Neurooncol. 2017. PMID: 28577031. doi:10.1007/s11060-017-2517-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。